Table 2

Treatment Effects for Osteopathic Manual Treatment and Ultrasound Therapy in Chronic Low Back Pain

LBP Reduction ThresholdaOMT RR (95% CI)UST RR (95% CI)
Intention-to-treat analysis (N = 455)
  ≥30%1.38 (1.16-1.64)1.02 (0.86-1.20)
  ≥50%1.41 (1.13-1.76)1.09 (0.88-1.35)
  ≥20 mm1.47 (1.17-1.86)1.01 (0.80-1.26)
  ≥40 mm1.96 (1.18-3.24)1.09 (0.68-1.75)
Per-protocol analysis (n = 362)
  ≥30%1.42 (1.19-1.70)1. 03 (0.87-1.23)
  ≥50%1.48 (1.18-1.86)1.11 (0.89-1.38)
  ≥20 mm1.44 (1.13-1.85)1.05 (0.83-1.34)
  ≥40 mm2.08 (1.21-3.58)1.01 (0.61-1.67)
Patients with missed treatments considered nonresponders (N = 455)
  ≥30%1.38 (1.13-1.69)0.97 (0.80-1.18)
  ≥50%1.43 (1.12-1.83)1.05 (0. 82-1.33)
  ≥20 mm1.40 (1.07-1.82)0.99 (0.77-1.28)
  ≥40 mm2.01 (1.16-3.49)0.95 (0.57-1.59)

Note: Response ratios are for active vs sham treatments. RR >1 potentially indicates some level of response to active treatment. Using the Cochrane Back Review Group guidelines,33 significant treatment effects are further classified as small, RR <1.25; medium, RR = 1.25 to ≤2.0; or large, RR >2. Thus, table entries for OMT effects were all in the medium to large range. There was no evidence of any treatment effect with UST, as no table entry achieved significance.

  • IMMPACT = Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials; LBP = low back pain; OMT = osteopathic manual treatment; RR = response ratio; UST = ultrasound therapy.

  • a IMMPACT benchmarks are ≥30% LBP reduction (moderate improvement) and ≥50% LBP reduction (substantial improvement).24 Using absolute pain measures on a 100-mm visual analog scale, benchmarks are ≥20 mm LBP reduction (moderate improvement) and ≥40 mm LBP reduction (substantial improvement).